Home › Companies › West Pharmaceutical Services, Inc. › 2025-2026

West Pharmaceutical Services, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and West Pharmaceutical Services, Inc.’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 16Reported items
  • 707Asset managers
  • 10,704Fund votes
  • 2026-05-04Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore West Pharmaceutical Services, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by West Pharmaceutical Services, Inc.

These tallies are West Pharmaceutical Services, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

West Pharmaceutical Services, Inc. — official shareholder meeting results, meeting held 2026-05-04
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Mark A. Buthman 62,394,9751,521,10634,356 --2,242,885 Majority: yes
Elect Director: William F. Feehery 61,427,3912,489,20233,844 --2,242,885 Majority: yes
Elect Director: Robert F. Friel 62,396,7551,521,67732,005 --2,242,885 Majority: yes
Elect Director: Eric M. Green 58,892,5324,573,928483,977 --2,242,885 Majority: yes
Elect Director: Janet B. Haugen 61,934,4091,987,18928,839 --2,242,885 Majority: yes
Elect Director: Molly E. Joseph 61,545,9562,341,35563,126 --2,242,885 Majority: yes
Elect Director: Deborah L. V. Keller 57,992,1625,599,392358,883 --2,242,885 Majority: yes
Elect Director: Myla P. Lai-Goldman 61,523,6422,395,04131,754 --2,242,885 Majority: yes
Elect Director: Stephen H. Lockhart 63,432,380470,84047,217 --2,242,885 Majority: yes
Elect Director: Douglas A. Michels 60,240,1413,670,80739,489 --2,242,885 Majority: yes
Elect Director: Paolo Pucci 62,930,048981,15239,237 --2,242,885 Majority: yes
Proposal 2: The non-binding advisory vote to approve the compensation of the Company's named executive officers was approved as set forth below. 60,107,8023,762,20680,429 --2,242,885 Passed
Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified as set forth below. 58,509,1197,556,514127,689 ---- Passed
Proposal 4: The shareholder proposal regarding an Independent Board Chair Policy was not approved as set forth below. 29,592,48834,245,125112,824 --2,242,885 Failed

Source: West Pharmaceutical Services, Inc., Form 8-K — read the filing on EDGAR.

How asset managers voted at the West Pharmaceutical Services, Inc. 2025-2026 meeting

Each item below shows how the 707 asset managers that disclosed a West Pharmaceutical Services, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of West Pharmaceutical Services, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote to approve named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Meeting held 2026-05-04.

Combines 11 wordings of this item as funds reported it.

94% Passed · of votes cast

FOR 94%
FOR: 60,107,802AGAINST: 3,762,206

West Pharmaceutical Services, Inc.’s own tally for this item (“Proposal 2: The non-binding advisory vote to approve the compensation of the Company's named executive officers was approved as set forth below.”): 60,107,802 for, 3,762,206 against — passed, per its Form 8-K (Item 5.07). Of all 70,647,595 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).

The 699 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 95%
FOR: 94.8%AGAINST: 5.2%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Advisory vote to approve named executive officer compensation.” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard9,567,85414,801 00For
BlackRock6,010,1471,635 00For
T. Rowe Price3,843,3580 00For
Artisan2,466,4240 00For
State Street2,134,9844,025 00For
Invesco1,955,1980 00For
GEODE CAPITAL MANAGEMENT, LLC1,888,6180 00For
Fidelity1,807,9740 00For
Walter Scott & Partners Ltd1,705,3410 00For
GENERATION INVESTMENT MANAGEMENT LLP1,512,5200 00For
BROWN ADVISORY INC1,393,1970 00For
APG Asset Management US Inc.01,325,495 00Against
Charles Schwab1,086,6230 00For
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC893,1600 00For
Longview Partners (Guernsey) LTD0814,625 00Against
American Century761,8900 00For
Calvert719,1280 00For
Northern Trust713,1530 00For
Amundi0679,198 00Against
ProShares666,7690 00For
Findlay Park Partners LLP660,0060 00For
Six Circles Trust628,4540 00For
VAN ECK ASSOCIATES CORP627,6350 00For
VanEck ETF Trust625,8870 00For
Capital Research Global Investors601,9680 00For

Showing the 25 largest of 699 asset managers. See all 699 in the interactive database.

2. Election of Directors: Deborah L. V. Keller

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 57,992,162AGAINST: 5,599,392

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Deborah L. V. Keller”): 57,992,162 for, 5,599,392 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 82% for, 8% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 98% of the shares they voted on this item FOR (24,680,188 for, 387,798 against).

FOR 98%
FOR: 24,680,188 (98.4%)AGAINST: 387,798 (1.5%)ABSTAIN: 2,850 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Deborah L. V. Keller” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,848,6659,057 30For
BlackRock2,313,509415 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,3550 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert0342,126 00Against
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

3. Election of Directors: Douglas A. Michels

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 60,240,141AGAINST: 3,670,807

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Douglas A. Michels”): 60,240,141 for, 3,670,807 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99% of the shares they voted on this item FOR (24,693,731 for, 374,257 against).

FOR 98%
FOR: 24,693,731 (98.5%)AGAINST: 374,257 (1.5%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Douglas A. Michels” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,69826 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,34015 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert0342,126 00Against
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

4. Election of Directors: Eric M. Green

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%
FOR: 58,892,532AGAINST: 4,573,928

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Eric M. Green”): 58,892,532 for, 4,573,928 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 83% for, 6% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99% of the shares they voted on this item FOR (24,724,216 for, 343,768 against).

FOR 99%
FOR: 24,724,216 (98.6%)AGAINST: 343,768 (1.4%)ABSTAIN: 2,851 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Eric M. Green” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,69723 40For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,3469 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert0342,126 00Against
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

5. Election of Directors: Janet B. Haugen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 61,934,409AGAINST: 1,987,189

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Janet B. Haugen”): 61,934,409 for, 1,987,189 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 88% for, 3% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99.9% of the shares they voted on this item FOR (25,067,975 for, 13 against).

FOR 99.9%
FOR: 25,067,975 (100.0%)AGAINST: 13 (0.0%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Janet B. Haugen” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,71113 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,3550 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

6. Election of Directors: Mark A. Buthman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 62,394,975AGAINST: 1,521,106

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Mark A. Buthman”): 62,394,975 for, 1,521,106 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 88% for, 2% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99.9% of the shares they voted on this item FOR (25,050,327 for, 17,661 against).

FOR 99.9%
FOR: 25,050,327 (99.9%)AGAINST: 17,661 (0.1%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Mark A. Buthman” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,71311 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,34015 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

7. Election of Directors: Molly E. Joseph

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 61,545,956AGAINST: 2,341,355

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Molly E. Joseph”): 61,545,956 for, 2,341,355 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 87% for, 3% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99% of the shares they voted on this item FOR (24,711,392 for, 356,596 against).

FOR 99%
FOR: 24,711,392 (98.6%)AGAINST: 356,596 (1.4%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Molly E. Joseph” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,70915 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,3550 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert0342,126 00Against
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

8. Election of Directors: Myla P. Lai-Goldman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 61,523,642AGAINST: 2,395,041

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Myla P. Lai-Goldman”): 61,523,642 for, 2,395,041 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 87% for, 3% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99.9% of the shares they voted on this item FOR (25,050,321 for, 17,667 against).

FOR 99.9%
FOR: 25,050,321 (99.9%)AGAINST: 17,667 (0.1%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Myla P. Lai-Goldman” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,70717 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,34015 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

9. Election of Directors: Robert F. Friel

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 62,396,755AGAINST: 1,521,677

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Robert F. Friel”): 62,396,755 for, 1,521,677 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 88% for, 2% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99% of the shares they voted on this item FOR (24,711,399 for, 356,588 against).

FOR 99%
FOR: 24,711,399 (98.6%)AGAINST: 356,588 (1.4%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Robert F. Friel” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,7167 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,3550 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert0342,126 00Against
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

10. Election of Directors: Stephen H. Lockhart

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 63,432,380AGAINST: 470,840

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Stephen H. Lockhart”): 63,432,380 for, 470,840 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 90% for, 0.7% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99.8% of the shares they voted on this item FOR (25,030,096 for, 37,892 against).

FOR 99.8%
FOR: 25,030,096 (99.8%)AGAINST: 37,892 (0.2%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Stephen H. Lockhart” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,842,93614,789 00For
BlackRock2,312,6671,257 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street913,6171,738 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

11. Election of Directors: William F. Feehery

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 61,427,391AGAINST: 2,489,202

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: William F. Feehery”): 61,427,391 for, 2,489,202 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 87% for, 4% against (90% of the company cast a for/against vote).

The 142 asset managers below cast 99.9% of the shares they voted on this item FOR (25,050,320 for, 17,667 against).

FOR 99.9%
FOR: 25,050,320 (99.9%)AGAINST: 17,667 (0.1%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: William F. Feehery” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,70617 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,34015 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

12. Election of Directors: Paolo Pucci

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-05-04.

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 62,930,048AGAINST: 981,152

West Pharmaceutical Services, Inc.’s own tally for this item (“Elect Director: Paolo Pucci”): 62,930,048 for, 981,152 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 89% for, 1% against (90% of the company cast a for/against vote).

The 141 asset managers below cast 99.9% of the shares they voted on this item FOR (25,039,996 for, 17,642 against).

FOR 99.9%
FOR: 25,039,996 (99.9%)AGAINST: 17,642 (0.1%)ABSTAIN: 2,847 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Election of Directors: Paolo Pucci” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,857,7177 00For
BlackRock2,313,9240 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,3550 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 141 asset managers. See all 141 in the interactive database.

13. Shareholder proposal regarding an independent Board Chair policy.

CORPORATE GOVERNANCECompany result: Failed

Meeting held 2026-05-04.

Combines 4 wordings of this item as funds reported it.

46.4% Failed · of votes cast

FOR 46.4%AGAINST 53.6%
FOR: 29,592,488AGAINST: 34,245,125

West Pharmaceutical Services, Inc.’s own tally for this item (“Proposal 4: The shareholder proposal regarding an Independent Board Chair Policy was not approved as set forth below.”): 29,592,488 for, 34,245,125 against — failed, per its Form 8-K (Item 5.07). Of all 70,647,595 outstanding shares: 42% for, 48.5% against (90% of the company cast a for/against vote).

The 141 asset managers below cast 29% of the shares they voted on this item FOR (7,201,389 for, 17,857,674 against).

FOR 29%AGAINST 71%
FOR: 7,201,389 (28.7%)AGAINST: 17,857,674 (71.3%)ABSTAIN: 1,420 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Shareholder proposal regarding an independent Board Chair policy.” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard38,3258,819,397 00Against
BlackRock2,5852,311,339 00Against
Fidelity3,2421,734,823 00Against
T. Rowe Price1,029,493204,175 00For
State Street471914,884 00Against
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust0628,454 00Against
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab124537,420 00Against
Brown Advisory Funds0430,876 00Against
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National270,514107,954 00For
American Century0362,605 00Against
TIAA0359,170 00Against
Calvert342,1260 00For
Bridge Builder Trust65,000269,044 00Against
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional0171,855 00Against
TRUST FOR PROFESSIONAL MANAGERS155,3787,506 00For
Empower81,26341,226 00For
Catholic Responsible Investments Funds115,8920 00For

Showing the 25 largest of 141 asset managers. See all 141 in the interactive database.

14. Ratification of the appointment of our independent registered public accounting firm for 2026.

AUDIT-RELATEDCompany result: Passed

Meeting held 2026-05-04.

Combines 3 wordings of this item as funds reported it.

89% Passed · of votes cast

FOR 89%11%
FOR: 58,509,119AGAINST: 7,556,514

West Pharmaceutical Services, Inc.’s own tally for this item (“Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified as set forth below.”): 58,509,119 for, 7,556,514 against — passed, per its Form 8-K (Item 5.07). Of all 70,647,595 outstanding shares: 83% for, 11% against (94% of the company cast a for/against vote).

The 140 asset managers below cast 99.3% of the shares they voted on this item FOR (24,892,468 for, 153,749 against).

FOR 99.3%
FOR: 24,892,468 (99.4%)AGAINST: 153,749 (0.6%)ABSTAIN: 1,420 (0.0%)NOT VOTED: 55 (0.0%)
Largest asset managers voting on “Ratification of the appointment of our independent registered public accounting firm for 2026.” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,848,6489,073 00For
BlackRock2,313,509415 00For
Fidelity1,738,0650 00For
T. Rowe Price1,233,6680 00For
State Street915,34015 00For
Invesco785,4150 00For
ProShares666,7690 00For
Six Circles Trust628,4540 00For
VanEck ETF Trust625,8870 00For
AMCAP FUND569,8870 00For
Charles Schwab537,5440 00For
Brown Advisory Funds430,8760 00For
Virtus407,7470 00For
FRANKLIN MANAGED TRUST388,5000 00For
Jackson National378,4680 00For
American Century362,6050 00For
TIAA359,1700 00For
Calvert342,1260 00For
Bridge Builder Trust334,0440 00For
First Trust214,4480 00For
Neuberger Berman192,6290 00For
Dimensional171,8550 00For
TRUST FOR PROFESSIONAL MANAGERS162,8840 00For
Empower122,4890 00For
Catholic Responsible Investments Funds0115,892 00Against

Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.

15. Advisory vote to approve named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-06 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 59,222,338AGAINST: 3,516,476

West Pharmaceutical Services, Inc.’s own tally for this item (“Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”): 59,222,338 for, 3,516,476 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,647,595 outstanding shares: 84% for, 5% against (89% of the company cast a for/against vote).

The 3 asset managers below cast 22% of the shares they voted on this item FOR (1,980 for, 7,161 against).

FOR 22%AGAINST 78%
FOR: 1,980 (21.7%)AGAINST: 7,161 (78.3%)
Largest asset managers voting on “Advisory vote to approve named executive officer compensation.” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
OSSIAM04,822 00Against
PENSIOENFONDS RAIL & OV02,339 00Against
Investment Management Corp of Ontario1,9800 00For

16. Advisory vote to approve named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTES

Reported under meeting date 2026-02-27; no official results on file for that date.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (133,653 for, 0 against).

FOR: 133,653 (100.0%)
Largest asset managers voting on “Advisory vote to approve named executive officer compensation.” at West Pharmaceutical Services, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
SCHRODER INVESTMENT MANAGEMENT GROUP133,6030 00For
Robertson Stephens Wealth Management, LLC500 00For

Largest West Pharmaceutical Services, Inc. shareholders voting in 2025-2026

Ranked by the number of West Pharmaceutical Services, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 70,647,595 shares outstanding at the time of that meeting.

Top West Pharmaceutical Services, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 13.56%
2BlackRock 8.51%
3T. Rowe Price 5.44%
4Artisan 3.49%
5State Street 3.03%
6Invesco 2.77%
7GEODE CAPITAL MANAGEMENT, LLC 2.67%
8Fidelity 2.56%
9Walter Scott & Partners Ltd 2.41%
10GENERATION INVESTMENT MANAGEMENT LLP 2.14%

Reported West Pharmaceutical Services, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

West Pharmaceutical Services, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 13.50% 13F
BlackRock 9.68% 13F
State Street 4.66% 13F
BNY Mellon 3.49% 13F
Geode Capital 2.71% 13F
Morgan Stanley 2.17% 13F
FMR (Fidelity) 1.77% 13F
Invesco 1.49% 13F
JPMorgan Chase 1.48% 13F
Northern Trust 1.04% 13F

Percentages above are of 70,647,595 shares outstanding, as reported by West Pharmaceutical Services, Inc. on its Form 10-Q dated 2026-04-20 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from West Pharmaceutical Services, Inc.’s 10-Q dated 2026-04-20. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At West Pharmaceutical Services, Inc.'s shareholder meeting held 2026-05-04, in the 2025-2026 proxy season, 707 asset managers reported how they voted in their SEC Form N-PX filings, covering 10,704 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — the proposal passed with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: West Pharmaceutical Services, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

West Pharmaceutical Services, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).